ICU Medical, Inc.
951 Calle Amanecer
San Clemente
California
92763
United States
Tel: 949-366-2183
Fax: 949-366-8368
Website: http://www.icumed.com/
233 articles about ICU Medical, Inc.
-
ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum
3/13/2024
ICU Medical today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024.
-
ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal Year 2024 Guidance
2/27/2024
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended December 31, 2023.
-
ICU Medical Announces Time of Fourth Quarter 2023 Earnings Conference Call
2/13/2024
ICU Medical, Inc. today announced the time of its fourth quarter 2023 earnings release and conference call.
-
ICU Medical Announces Third Quarter 2023 Results
11/6/2023
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended September 30, 2023.
-
ICU Medical Announces Time of Third Quarter 2023 Earnings Conference Call
10/23/2023
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2023 earnings release and conference call.
-
ICU Medical Receives FDA Clearance for Plum Duo™ Infusion Pump and LifeShield™ Infusion Safety Software
8/29/2023
ICU Medical Inc., a worldwide leader in the development, manufacture and sale of innovative medical devices, today announced that the company has received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Plum Duo infusion pump with LifeShield infusion safety software.
-
ICU Medical Announces Second Quarter 2023 Results and Narrows Fiscal Year 2023 Guidance Ranges
8/7/2023
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended June 30, 2023.
-
ICU Medical Announces Time of Second Quarter 2023 Earnings Conference Call
7/24/2023
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2023 earnings release and conference call.
-
ICU Medical Announces First Quarter 2023 Results
5/8/2023
ICU Medical, Inc., a leader in the development, manufacture and sale of innovative medical products, announced financial results for the quarter ended March 31, 2023.
-
ICU Medical Announces Time of First Quarter 2023 Earnings Conference Call
4/24/2023
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2023 earnings release and conference call.
-
ICU Medical to Participate at the KeyBanc Life Sciences & MedTech Investor Forum
3/9/2023
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum at 7:30 a.m. PT (10:30 a.m. ET) on Wednesday, March 22, 2023.
-
ICU Medical Announces Fourth Quarter 2022 Results and Provides Fiscal Year 2023 Guidance
2/27/2023
ICU Medical, Inc., a leader in the development, manufacture and sale of innovative medical products, announced financial results for the quarter ended December 31, 2022.
-
ICU Medical to Present at the Raymond James 44th Annual Institutional Investors Conference
2/21/2023
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 44th Annual Institutional Investors Conference being held in Orlando, Florida, March 5-8, 2023.
-
ICU Medical Announces Time of Fourth Quarter 2022 Earnings Conference Call
2/13/2023
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2022 earnings release and conference call.
-
ICU Medical to Present at the J.P. Morgan 41st Annual Healthcare Conference
12/19/2022
ICU Medical, (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the J.P. Morgan 41st Annual Healthcare Conference, being held in San Francisco, CA, January 9-12, 2023.
-
ICU Medical Announces Third Quarter 2022 Results
11/7/2022
ICU Medical, Inc., a leader in the development, manufacture and sale of innovative medical products, announced financial results for the quarter ended September 30, 2022.
-
ICU Medical Announces Time of Third Quarter 2022 Earnings Conference Call
10/6/2022
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2022 earnings release and conference call.
-
ICU Medical to Participate at the Morgan Stanley 20th Annual Global Healthcare Conference
9/8/2022
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Morgan Stanley Annual Global Healthcare Conference at 11:15 a.m. PT (2:15 p.m. ET) on Monday, September 12, 2022.
-
ICU Medical Announces Second Quarter 2022 ResultsCompany Updated FY 2022 Guidance
8/8/2022
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended June 30, 2022.
-
ICU Medical, Inc. Announces Time of Second Quarter 2022 Earnings Conference Call
7/19/2022
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2022 earnings release and conference call.